News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
GENEART AG Shareholders’ Meeting Onboard for Continued Growth
July 24, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
REGENSBURG, GERMANY--(MARKET WIRE)--Jul 24, 2007 -- - Shareholders fully approve the growth strategy pursued by the Board of Directors - Resolutions in favor of a capital increase out of capital reserves
Twitter
LinkedIn
Facebook
Email
Print
Events
Europe
MORE ON THIS TOPIC
Insights
Can Europe turn world-class science into world-class scale?
April 16, 2026
·
5 min read
·
Jennifer C. Smith-Parker
Rare diseases
Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency With Rigor
April 2, 2026
·
6 min read
·
Heather McKenzie
Drug pricing
Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling
April 2, 2026
·
3 min read
·
Annalee Armstrong
Drug pricing
Trump’s MFN Pricing Expected To Delay More European Drug Launches
April 1, 2026
·
3 min read
·
Nick Paul Taylor
